Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Cardiovascular Ultrasound|June 8, 2015
Echocardiographic characteristics of patients with acute heart failure requiring tolvaptan: a retrospective studyYasuki Nakada, Satoshi Okayama, Tomoya Nakano, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 1, 2015
Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EFTomoya Ueda, Rika Kawakami, Taku Nishida, et al.
JACC. Case Reports|March 13, 2026
Apolipoprotein A-IV Cardiac Amyloidosis Diagnosed by Mass Spectrometry-Based Proteomic AnalysisYu Masutani, Kenji Onoue, Tsunenari Soeda, et al.
Atherosclerosis|April 26, 2011
Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesionsNobuhiro Zaima, Takeshi Sasaki, Hiroki Tanaka, et al.
Frontiers in Cardiovascular Medicine|July 12, 2021
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna MutationKenji Onoue, Hiroko Wakimoto, Jiangming Jiang, et al.
Heart and Vessels|March 27, 2010
Novel application of black-blood echo-planar imaging to the assessment of myocardial infarctionSatoshi Okayama, Shiro Uemura, Makoto Watanabe, et al.
Circulation Reports|August 12, 2024
Effects of Cardioprotective Drugs on 90-Day Mortality or Heart Transplantation in Patients With Fulminant MyocarditisShuhei Tara, Takeshi Yamamoto, Koshiro Kanaoka, et al.
Circulation|September 27, 2022
Features and Outcomes of Histologically Proven Myocarditis With Fulminant PresentationKoshiro Kanaoka, Kenji Onoue, Satoshi Terasaki, et al.
Scientific Reports|November 21, 2025
Prognostic nutritional index in risk of mortality following fulminant myocarditisShunichi Doi, Yuki Ishibashi, Norio Suzuki, et al.
Pageof 11